Please use this identifier to cite or link to this item: https://essuir.sumdu.edu.ua/handle/123456789/87789
Or use following links to share this resource in social networks: Recommend this item
Title Ketamine administration in early postnatal life as a tool for mimicking Autism Spectrum Disorders core symptoms
Authors Bove, M.
Schiavone, S.
Tucci, P.
Sikora, Vladyslav Volodymyrovych  
Dimonte, S.
Colia, A.L.
Morgese, M.G.
Trabace, L.
ORCID http://orcid.org/0000-0002-4147-6879
Keywords Autism Spectrum Disorders
Ketamine
GABA
Glutamate
Animal model
Type Article
Date of Issue 2022
URI https://essuir.sumdu.edu.ua/handle/123456789/87789
Publisher Elsevier Inc.
License Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International
Citation Bove, M., Schiavone, S., Tucci, P., Sikora, V., Dimonte, S., Colia, A. L., . . . Trabace, L. (2022). Ketamine administration in early postnatal life as a tool for mimicking autism spectrum disorders core symptoms. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117 doi:10.1016/j.pnpbp.2022.110560
Abstract Autism Spectrum Disorders (ASD) core symptoms include deficits of social interaction, stereotyped behaviours, dysfunction in language and communication. Beyond them, several additional symptoms, such as cognitive impairment, anxiety-like states and hyperactivity are often occurring, mainly overlapping with other neuropsychiatric diseases. To untangle mechanisms underlying ASD etiology, and to identify possible pharmacological approaches, different factors, such as environmental, immunological and genetic ones, need to be considered. In this context, ASD animal models, aiming to reproduce the wide range of behavioural phenotypes of this uniquely human disorder, represent a very useful tool. Ketamine administration in early postnatal life of mice has already been studied as a suitable animal model resembling psychotic-like symptoms. Here, we investigated whether ketamine administration, at postnatal days 7, 9 and 11, might induce behavioural features able to mimic ASD typical symptoms in adult mice. To this aim, we developed a 4-days behavioural tests battery, including Marble Burying, Hole Board, Olfactory and Social tests, to assess repetitive and stereotyped behaviour, social deficits and anxiety-like symptoms. Moreover, by using this mouse model, we performed neurochemical and biomolecular analyses, quantifying neurotransmitters belonging to excitatory-inhibitory pathways, such as glutamate, glutamine and gamma-aminobutyric acid (GABA), as well as immune activation biomarkers related to ASD, such as CD11b and glial fibrillary acidic protein (GFAP), in the hippocampus and amygdala. Possible alterations in levels of brain-derived neurotrophic factor (BDNF) expression in the hippocampus and amygdala were also evaluated. Our results showed an increase in stereotyped behaviours, together with social impairments and anxiety-like behaviour in adult mice, receiving ketamine administration in early postnatal life. In addition, we found decreased BDNF and enhanced GFAP hippocampal expression levels, accompanied by elevations in glutamate amount, as well as reduction in GABA content in amygdala and hippocampus. In conclusion, early ketamine administration may represent a suitable animal model of ASD, exhibiting face validity to mimic specific ASD symptoms, such as social deficits, repetitive repertoire and anxiety-like behaviour.
Appears in Collections: Наукові видання (НН МІ)

Views

Greece Greece
1
Ireland Ireland
1177
Singapore Singapore
158595
Turkey Turkey
1
Ukraine Ukraine
19913
United Kingdom United Kingdom
8667
United States United States
317188
Unknown Country Unknown Country
505766
Vietnam Vietnam
222

Downloads

Australia Australia
452
Belgium Belgium
1
Brazil Brazil
1
Canada Canada
1
China China
158591
Ethiopia Ethiopia
1
Germany Germany
1
Hong Kong SAR China Hong Kong SAR China
1
Indonesia Indonesia
1
Ireland Ireland
68636
Italy Italy
98622
Japan Japan
1
Kenya Kenya
1
Latvia Latvia
1
Macao SAR China Macao SAR China
1
Mexico Mexico
1
Pakistan Pakistan
1
Peru Peru
1
Poland Poland
1
Saudi Arabia Saudi Arabia
1
South Africa South Africa
1
South Korea South Korea
454
Spain Spain
1
Sweden Sweden
1
Taiwan Taiwan
1
Ukraine Ukraine
19914
United Kingdom United Kingdom
68638
United States United States
317187
Unknown Country Unknown Country
1
Vietnam Vietnam
1

Files

File Size Format Downloads
Bove_et_al_Autism_Spectrum_Disorders_2022.pdf 1.39 MB Adobe PDF 732516

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.